These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23041609)

  • 1. Liver X receptor α bidirectionally transactivates human CYP1A1 and CYP1A2 through two cis-elements common to both genes.
    Araki K; Watanabe K; Yamazoe Y; Yoshinari K
    Toxicol Lett; 2012 Nov; 215(1):16-24. PubMed ID: 23041609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5'-flanking region.
    Yoshinari K; Yoda N; Toriyabe T; Yamazoe Y
    Biochem Pharmacol; 2010 Jan; 79(2):261-9. PubMed ID: 19682433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements.
    Yoshinari K; Ueda R; Kusano K; Yoshimura T; Nagata K; Yamazoe Y
    Biochem Pharmacol; 2008 Jul; 76(1):139-45. PubMed ID: 18502397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1.
    Meyer Zu Schwabedissen HE; Böttcher K; Chaudhry A; Kroemer HK; Schuetz EG; Kim RB
    Hepatology; 2010 Nov; 52(5):1797-807. PubMed ID: 20827719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSU-16, (Z)-3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, is a potent activator of aryl hydrocarbon receptor and increases CYP1A1 and CYP1A2 expression in human hepatocytes.
    Matsuoka-Kawano K; Yoshinari K; Nagayama S; Yamazoe Y
    Chem Biol Interact; 2010 Apr; 185(1):33-41. PubMed ID: 20171196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes.
    Ueda R; Iketaki H; Nagata K; Kimura S; Gonzalez FJ; Kusano K; Yoshimura T; Yamazoe Y
    Mol Pharmacol; 2006 Jun; 69(6):1924-30. PubMed ID: 16505155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes.
    Vrzal R; Stejskalova L; Monostory K; Maurel P; Bachleda P; Pavek P; Dvorak Z
    Chem Biol Interact; 2009 May; 179(2-3):288-96. PubMed ID: 19022236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor.
    Shi Z; Chen Y; Dong H; Amos-Kroohs RM; Nebert DW
    Biochem Biophys Res Commun; 2008 Nov; 376(4):775-80. PubMed ID: 18814841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed-ligand copper(II) complexes activate aryl hydrocarbon receptor AhR and induce CYP1A genes expression in human hepatocytes and human cell lines.
    Kubešová K; Dořičáková A; Trávníček Z; Dvořák Z
    Toxicol Lett; 2016 Jul; 255():24-35. PubMed ID: 27180721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2.
    Cheung C; Ma X; Krausz KW; Kimura S; Feigenbaum L; Dalton TP; Nebert DW; Idle JR; Gonzalez FJ
    Chem Res Toxicol; 2005 Sep; 18(9):1471-8. PubMed ID: 16167840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual roles of nuclear receptor liver X receptor α (LXRα) in the CYP3A4 expression in human hepatocytes as a positive and negative regulator.
    Watanabe K; Sakurai K; Tsuchiya Y; Yamazoe Y; Yoshinari K
    Biochem Pharmacol; 2013 Aug; 86(3):428-36. PubMed ID: 23732298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes.
    Dvorak Z; Vrzal R; Henklova P; Jancova P; Anzenbacherova E; Maurel P; Svecova L; Pavek P; Ehrmann J; Havlik R; Bednar P; Lemr K; Ulrichova J
    Biochem Pharmacol; 2008 Jan; 75(2):580-8. PubMed ID: 17959153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR.
    Okuwaki M; Takada T; Iwayanagi Y; Koh S; Kariya Y; Fujii H; Suzuki H
    Pharm Res; 2007 Feb; 24(2):390-8. PubMed ID: 17177110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a system that simultaneously evaluates CYP1A1 and CYP1A2 induction in a stable human-derived cell line using a dual reporter plasmid.
    Sato W; Suzuki H; Sasaki T; Kumagai T; Sakaguchi S; Mizugaki M; Miyairi S; Yamazoe Y; Nagata K
    Drug Metab Pharmacokinet; 2010; 25(2):180-9. PubMed ID: 20460824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation of ABCG2 through a novel cis-element in the distal promoter by constitutive androstane receptor but not pregnane X receptor in human hepatocytes.
    Benoki S; Yoshinari K; Chikada T; Imai J; Yamazoe Y
    Arch Biochem Biophys; 2012 Jan; 517(2):123-30. PubMed ID: 22093699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the gene for CYP1A2, which is expressed primarily in liver, leads to differential regulation of hepatic and pulmonary mouse CYP1A1 expression and augmented human CYP1A1 transcriptional activation in response to 3-methylcholanthrene in vivo.
    Jiang W; Wang L; Kondraganti SR; Fazili IS; Couroucli XI; Felix EA; Moorthy B
    J Pharmacol Exp Ther; 2010 Nov; 335(2):369-79. PubMed ID: 20732958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.
    Jiang Z; Dalton TP; Jin L; Wang B; Tsuneoka Y; Shertzer HG; Deka R; Nebert DW
    Hum Mutat; 2005 Feb; 25(2):196-206. PubMed ID: 15643613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand.
    Knebel C; Kebben J; Eberini I; Palazzolo L; Hammer HS; Süssmuth RD; Heise T; Hessel-Pras S; Lampen A; Braeuning A; Marx-Stoelting P
    Arch Toxicol; 2018 Dec; 92(12):3471-3486. PubMed ID: 30293151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytochrome P450 1A1 is a novel target gene of liver X receptor α.
    Shibahara N; Masunaga Y; Iwano S; Yamazaki H; Kiyotani K; Kamataki T
    Drug Metab Pharmacokinet; 2011; 26(5):451-7. PubMed ID: 21646728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4alpha requires coactivators peroxisomal proliferator activated receptor-gamma coactivator 1alpha and steroid receptor coactivator 1.
    Martínez-Jiménez CP; Castell JV; Gómez-Lechón MJ; Jover R
    Mol Pharmacol; 2006 Nov; 70(5):1681-92. PubMed ID: 16882880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.